Scarica l'app Stockscreener
1.81
6.70%
-0.13
Dopo l'orario di chiusura:
1.78
-0.03
-1.66%
Precedente Chiudi:
$1.94
Aprire:
$1.96
Volume 24 ore:
3.89M
Relative Volume:
0.47
Capitalizzazione di mercato:
$270.06M
Reddito:
-
Utile/perdita netta:
$-14.07M
Rapporto P/E:
-0.1294
EPS:
-13.99
Flusso di cassa netto:
$-12.56M
1 W Prestazione:
+0.00%
1M Prestazione:
-15.42%
6M Prestazione:
+182.77%
1 anno Prestazione:
+2.26%
Intervallo 1D:
$1.7801
$1.98
Intervallo di 1 settimana:
$1.73
$2.27
Portata 52W:
$0.53
$2.59
Palisade Bio Inc Stock (PALI) Company Profile
Nome
Palisade Bio Inc
Settore
Industria
Telefono
(858) 704-4900
Indirizzo
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Confronta PALI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
1.81 | 289.45M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Palisade Bio Inc Borsa (PALI) Ultime notizie
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Palisade Bio Inc - GuruFocus
Palisade Bio Stock Soars as Clinical Workforce Expands with New VP Appointment - StocksToTrade
Palisade Bio Stock Surge: What’s Behind the Rise? - StocksToTrade
Palisade Bio’s Vice President Appointment and UC Trial Success Boost Confidence - timothysykes.com
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision - ts2.tech
Palisade Bio (NASDAQ:PALI) Trading Up 0.6%Here's What Happened - MarketBeat
Palisade Bio (NASDAQ:PALI) Trading Up 0.6% – Here’s What Happened - Defense World
How does Palisade Bio Inc (PALI) change from a tortoise to a hare? - setenews.com
Retail Surge: What earnings margins imply for Palisade Bio Inc 7NS0 stock2025 Macro Impact & AI Based Buy/Sell Signal Reports - moha.gov.vn
EBIT per share of Palisade Bio, Inc. – MUN:7NS0 - TradingView
Aug Mood: Is Palisade Bio Inc stock a good choice for value investorsJuly 2025 Outlook & Expert Verified Stock Movement Alerts - moha.gov.vn
Palisade Bio Inc. (PALI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Palisade Bio Inc. stock ready for breakoutQuarterly Portfolio Summary & Growth-Oriented Investment Plans - Newser
Palisade Bio increases authorized common shares following stockholder approval By Investing.com - Investing.com Nigeria
Palisade Bio increases authorized common shares following stockholder approval - Investing.com
Is Palisade Bio Inc. stock a buy before product launchesEarnings Beat & Weekly High Conviction Trade Ideas - Newser
How Palisade Bio Inc. (7NS0) stock correlates with oil markets2025 Top Decliners & Fast Gain Swing Trade Alerts - Newser
Will Palisade Bio Inc. stock beat EPS estimates2025 Fundamental Recap & Weekly Momentum Stock Picks - Newser
Will Palisade Bio Inc. (7NS0) stock profit from AI boomGlobal Markets & Reliable Intraday Trade Plans - Newser
Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development - markets.businessinsider.com
Palisade Bio appoints James Izanec as VP of clinical development By Investing.com - Investing.com Australia
Palisade Bio appoints James Izanec as VP of clinical development - Investing.com
Palisade Bio Appoints Dr. James Izanec as Vice President of Clinical Development - Quiver Quantitative
Palisade Bio strengthens clinical leadership team with appointment of James Izanec - marketscreener.com
Palisade Bio Strengthens Clinical Leadership Team with - GlobeNewswire
Can Palisade Bio Inc. stock weather global recession2025 Price Momentum & Short-Term Trading Alerts - Newser
Will Palisade Bio Inc. (7NS0) stock announce special dividendJuly 2025 Short Interest & Capital Efficiency Focused Strategies - Newser
What is Palisade Bio Inc (PALI) Stock Return on Shareholders’ Capital? - setenews.com
How geopolitical risks impact Palisade Bio Inc. (7NS0) stockMarket Growth Report & Free Real-Time Volume Trigger Notifications - BỘ NỘI VỤ
Is Palisade Bio Inc. stock a good choice for value investorsMarket Trend Summary & Technical Buy Zone Confirmation - moha.gov.vn
What is the Price Targets for Palisade Bio Inc (PALI)? - fostersleader.com
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire
The time has not yet come to remove your chips from the table: Palisade Bio Inc (PALI) - Setenews
What analysts say about Palisade Bio Inc stockStock Liquidity Analysis & Tap Into the Fastest-Growing Companies - earlytimes.in
How big funds are accumulating Palisade Bio Inc. (7NS0) stockJuly 2025 Pullbacks & High Accuracy Investment Signals - newser.com
How Palisade Bio Inc. stock performs after earnings2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
Can Palisade Bio Inc. stock attract ESG capital inflowsWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
Individual investors are Palisade Bio, Inc.'s (NASDAQ:PALI) biggest owners and were rewarded after market cap rose by US$70m last week - Yahoo Finance
Free cash flow per share of Palisade Bio, Inc. – FWB:7NS0 - TradingView
Using RSI to spot recovery in Palisade Bio Inc.2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Will Palisade Bio Inc. stock deliver consistent dividendsMarket Rally & Weekly High Return Opportunities - newser.com
Will Palisade Bio Inc. (7NS0) stock deliver compounding returnsM&A Rumor & Real-Time Sentiment Analysis - newser.com
Using data filters to optimize entry into Palisade Bio Inc.2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Palisade Bio Inc Azioni (PALI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):